We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.49B
1-Year Est. Return
19.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+19.44%
3 Year Est. Return
+59.91%
5 Year Est. Return
+54.26%
10 Year Est. Return
+227.54%
AUM
$3.87B
AUM Growth
+$9.15M
(+0.24%)
Cap. Flow
-$43.3M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
66.62%
Holding
371
New
17
Increased
68
Reduced
106
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
|
+$90.5M |
| 2 |
Goldman Sachs
GS
|
+$39.1M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$38.1M |
| 4 |
Nike
NKE
|
+$7.43M |
| 5 |
Medtronic
MDT
|
+$7.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$117M |
| 2 |
Johnson & Johnson
JNJ
|
+$30.9M |
| 3 |
NVIDIA
NVDA
|
+$17.4M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$14.5M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 78.76% |
| 2 | Technology | 5.21% |
| 3 | Healthcare | 4.04% |
| 4 | Financials | 3.05% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boston Scientific
BSX
$68B
| $1.39K | ﹤0.01% |
18
-5
| -22% | -$366 |
|
102
Intercontinental Exchange
ICE
$92.4B
| $1.37K | ﹤0.01% |
10
+8
| +400% | +$1.07K |
|
103
Stryker
SYK
$118B
| $1.36K | ﹤0.01% |
4
-1
| -20% | -$339 |
|
104
Cigna
CI
$75.6B
| $1.32K | ﹤0.01% |
4
-1
| -20% | -$345 |
|
105
Philip Morris
PM
$290B
| $1.32K | ﹤0.01% |
13
| – | – |
|
106
Advanced Micro Devices
AMD
$745B
| $1.3K | ﹤0.01% |
8
-1
| -11% | -$161 |
|
107
McDonald's
MCD
$184B
| $1.27K | ﹤0.01% |
5
| – | – |
|
108
KKR & Co
KKR
$98.5B
| $1.26K | ﹤0.01% |
+12
| New | +$1.22K |
|
109
Moody's
MCO
$87.3B
| $1.26K | ﹤0.01% |
3
+2
| +200% | +$796 |
|
110
Southern Company
SO
$102B
| $1.24K | ﹤0.01% |
16
-1
| -6% | -$76 |
|
111
CME Group
CME
$101B
| $1.18K | ﹤0.01% |
6
+5
| +500% | +$1.03K |
|
112
McKesson
MCK
$107B
| $1.17K | ﹤0.01% |
2
| – | – |
|
113
Oracle
ORCL
$444B
| $1.13K | ﹤0.01% |
8
-1
| -11% | -$124 |
|
114
Wells Fargo
WFC
$270B
| $1.13K | ﹤0.01% |
19
+5
| +36% | +$295 |
|
115
Adobe
ADBE
$114B
| $1.11K | ﹤0.01% |
2
-1
| -33% | -$484 |
|
116
Gilead Sciences
GILD
$188B
| $1.1K | ﹤0.01% |
16
-4
| -20% | -$267 |
|
117
Lam Research
LRCX
$366B
| $1.06K | ﹤0.01% |
10
| – | – |
|
118
Regeneron Pharmaceuticals
REGN
$86.8B
| $1.05K | ﹤0.01% |
1
-1
| -50% | -$969 |
|
119
Cisco
CSCO
$428B
| $1.04K | ﹤0.01% |
22
-1
| -4% | -$47 |
|
120
Zoetis
ZTS
$31.5B
| $1.04K | ﹤0.01% |
6
-1
| -14% | -$166 |
|
121
Bristol-Myers Squibb
BMY
$139B
| $1.04K | ﹤0.01% |
25
-8
| -24% | -$358 |
|
122
Constellation Energy
CEG
$101B
| $1K | ﹤0.01% |
5
| – | – |
|
123
Texas Instruments
TXN
$232B
| $973 | ﹤0.01% |
5
| – | – |
|
124
CVS Health
CVS
$124B
| $945 | ﹤0.01% |
16
-4
| -20% | -$250 |
|
125
Applied Materials
AMAT
$346B
| $944 | ﹤0.01% |
4
-1
| -20% | -$215 |
|
Similar funds
WSFS
5NCM
DACG
MAM
U
ACM
EFM
WestEnd Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, WestEnd Advisors held 371 positions worth $3.87B, up 0.24% from $3.86B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
WestEnd Advisors's Q2 2024 filing shows 17 new, 68 increased, 106 reduced and 6 closed positions. Its largest new stake was iShares US Broker-Dealers & Securities Exchanges ETF: 785,417 shares worth $91.8M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $117M.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- WestEnd Advisors's largest Q2 2024 buy was iShares US Broker-Dealers & Securities Exchanges ETF: 785,417 shares worth $91.8M.
- WestEnd Advisors added most to Goldman Sachs in Q2 2024, an estimated $39.1M increase.
- WestEnd Advisors's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $117M.
- WestEnd Advisors fully exited iShares MSCI France ETF in Q2 2024, selling an estimated $138K.
- WestEnd Advisors's ten largest holdings make up 67% of its $3.87B portfolio in Q2 2024.
- WestEnd Advisors opened 17 new positions and closed 6 in Q2 2024.
- WestEnd Advisors's portfolio value rose 0.24% quarter-over-quarter to $3.87B.
Based on WestEnd Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.